CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Portola Pharmaceuticals Inc Company Snapshot
Portola Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Portola Pharmaceuticals Inc with three other companies in this sector in the United States: Caladrius Biosciences Inc (2016 sales of $35.28 million of which 100% was PCT Segment), Aratana Therapeutics Inc ($38.55 million ), and Jounce Therapeutics Inc ($37.20 million ).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Portola Pharmaceuticals Inc were $35.50 million. This is an increase of 194.2% versus 2015, when the company's sales were $12.07 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Portola Pharmaceuticals Inc
  Stock Performance Chart for Portola Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2017): 50.65
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks -6.4%  
4 Weeks -23.3%   52 Weeks 163.4%  
 
Portola Pharmaceuticals Inc Key Data:
  Ticker: PTLA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 35,504,000
(Year Ending Jan 2017).
Employees: 163
  Currency: U.S. Dollars Market Cap: 3,250,283,335
  Fiscal Yr Ends: December Shares Outstanding: 64,171,438
  Share Type: Common Closely Held Shares: 342,193
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.